These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38288472)

  • 1. Association between Lipoprotein(a) and diabetic nephropathy in patients with type 2 diabetes.
    Li M; Wang Y; Yao Q; Liang Q; Zhang Y; Wang X; Li Q; Qiang W; Yang J; Shi B; He M
    Front Endocrinol (Lausanne); 2023; 14():1337469. PubMed ID: 38288472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between lipoprotein(a) plasma levels and diabetic nephropathy in Han Chinese patients with type 2 diabetes mellitus.
    Wang T
    PLoS One; 2024; 19(5):e0299240. PubMed ID: 38743736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
    Zhai Y; Cao X; Liu S; Shen Y
    Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Lipoprotein (A) and Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis.
    Ren X; Zhang Z; Yan Z
    Front Endocrinol (Lausanne); 2021; 12():633529. PubMed ID: 33841331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for diabetic nephropathy complications in community patients with type 2 diabetes mellitus in Shanghai: Logistic regression and classification tree model analysis.
    Lou J; Jing L; Yang H; Qin F; Long W; Shi R
    Int J Health Plann Manage; 2019 Jul; 34(3):1013-1024. PubMed ID: 31368138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Lipoprotein(a) and High-Density Lipoprotein Cholesterol Associate with Diabetic Nephropathy: Evidence from Machine Learning Perspectives.
    Gao RH; Liu B; Yang Y; Ran R; Zhou Y; Liu SM
    Diabetes Metab Syndr Obes; 2023; 16():1847-1858. PubMed ID: 37378072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of diabetic nephropathy with the severity of obstructive sleep apnea-hypopnea syndrome in patients with type 2 diabetes mellitus.
    Dong M; Guo F; Zhou T; Wei Q
    Endocr J; 2020 May; 67(5):515-522. PubMed ID: 32023571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of intravoxel incoherent motion diffusion-weighted imaging in distinguishing diabetic nephropathy from non-diabetic renal disease in diabetic patients].
    Zhou SP; Wang Q; Zhai X; Chen P; Zhao J; Bai X; Zhang XJ; Li L; Ye HY; Dong ZY; Chen XM; Wang HY
    Zhonghua Nei Ke Za Zhi; 2023 Nov; 62(11):1288-1294. PubMed ID: 37935494
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population.
    Younas H; Ijaz T; Choudhry N
    PLoS One; 2022; 17(2):e0264038. PubMed ID: 35176079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoprotein(a) levels and diabetic nephropathy among Japanese patients with type 2 diabetes mellitus.
    Senba H; Furukawa S; Sakai T; Niiya T; Miyake T; Yamamoto S; Ueda T; Torisu M; Minami H; Miyaoka H; Onji M; Tanaka K; Matsuura B; Tanigawa T; Hiasa Y; Miyake Y
    J Diabetes Complications; 2016 Jul; 30(5):923-7. PubMed ID: 26947887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus.
    Li M; Fan R; Peng X; Huang J; Zou H; Yu X; Yang Y; Shi X; Ma D
    Front Endocrinol (Lausanne); 2021; 12():695750. PubMed ID: 34603198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.
    Lv WS; Sun RX; Gao YY; Wen JP; Pan RF; Li L; Wang J; Xian YX; Cao CX; Zheng M
    World J Gastroenterol; 2013 May; 19(20):3134-42. PubMed ID: 23716995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Globulin and Diabetic Nephropathy in Type2 Diabetes Mellitus Patients: A Cross-Sectional Study.
    Wang J; Liu F; Kong R; Han X
    Front Endocrinol (Lausanne); 2022; 13():890273. PubMed ID: 35898464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between RBC folate and diabetic nephropathy in Type2 diabetes mellitus patients: a cross-sectional study.
    Yu P; Ji Y; Wang H; Liu K
    Sci Rep; 2024 Oct; 14(1):24692. PubMed ID: 39433832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-pathological features of diabetic and non-diabetic renal diseases in type 2 diabetic patients: a retrospective study from a 10-year experience in a single center.
    Sun Y; Ren Y; Lan P; Yu X; Feng J; Hao D; Xie L
    Int Urol Nephrol; 2023 Sep; 55(9):2303-2312. PubMed ID: 36879071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
    Liu Q; Wang M; Xu T; Liang W; Yang F
    J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han's patients with type 1 diabetes mellitus.
    Li X; Zhang L; Chen H; Guo K; Yu H; Zhou J; Li M; Li Q; Li L; Yin J; Liu F; Bao Y; Han J; Jia W
    BMC Nephrol; 2017 Mar; 18(1):114. PubMed ID: 28363276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Lipocalin-2 Levels Are Increased and Independently Associated With Early-Stage Renal Damage and Carotid Atherosclerotic Plaque in Patients With T2DM.
    Gan J; Zheng Y; Yu Q; Zhang Y; Xie W; Shi Y; Yu N; Yan Y; Lin Z; Yang H
    Front Endocrinol (Lausanne); 2022; 13():855616. PubMed ID: 35547005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
    Huang JX; Liao YF; Li YM
    Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study.
    Wu Y; Liu F
    J Diabetes Complications; 2022 Aug; 36(8):108235. PubMed ID: 35853763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.